These findings provided a reliable evidence that p53 exhibited a beneficial effect on skeletal muscle by either promoting DNA repair through activation of RRM2B or ameliorating insulin resistance, which in turn mitigated the sarcopenia. The gene discussed is RRM2B; the disease is sarcopenia.